Khemani Distributors & Marketing Limited (BOM:539788)
113.65
0.00 (0.00%)
At close: Aug 24, 2026
BOM:539788 Revenue
In the fiscal year ending March 31, 2026, Khemani Distributors & Marketing had annual revenue of 793.63M INR, down -13.85%. Khemani Distributors & Marketing had revenue of 214.70M in the half year ending March 31, 2026, a decrease of -52.58%.
Revenue
793.63M
Revenue Growth
-13.85%
P/S Ratio
3.29
Revenue / Employee
29.39M
Employees
27
Market Cap
2.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 793.63M | -127.56M | -13.85% |
| Mar 31, 2025 | 921.18M | -198.39M | -17.72% |
| Mar 31, 2024 | 1.12B | 305.84M | 37.58% |
| Mar 31, 2023 | 813.74M | 125.18M | 18.18% |
| Mar 31, 2022 | 688.56M | 75.50M | 12.31% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chemkart India | 2.15B |
| Rama Vision | 1.76B |
| Novelix Pharmaceuticals | 1.47B |
| Chandra Bhagat Pharma | 1.17B |
| VijayPD Ceutical | 1.04B |
| Medico Intercontinental | 845.82M |
| Aptus Pharma | 465.75M |
| Constronics Infra | 454.43M |